Cancer Medication Shortages Create Access Barriers

Cancer medicines remain in short supply across the U.S., survey finds

A recent survey indicates life-saving cancer treatments face persistent shortages in the U.S., directly causing patients to experience delays or denials of critical care. This friction in access reflects systemic gaps in medication availability that undermine treatment continuity.

This shortage dynamic creates friction for patients needing cancer therapies—reducing the ability to receive timely, life-sustaining care. When essential medicines are unavailable, the path to treatment becomes obstructed, worsening health outcomes for those dependent on these interventions.

The source provides only this statistical finding without detail. A reader must consult the original survey for specific scope, methodology, or regional variations.

Source: STAT